Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1987 2
1988 7
1989 1
1990 1
1991 11
1992 6
1993 12
1994 5
1995 8
1996 6
1997 9
1998 6
1999 5
2000 5
2001 5
2002 8
2003 10
2004 6
2005 11
2006 5
2007 7
2008 10
2009 5
2010 6
2011 6
2012 10
2013 5
2014 7
2015 9
2016 10
2017 10
2018 20
2019 6
2020 9
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

243 results
Results by year
Filters applied: . Clear all
Page 1
Perspective for Precision Medicine for Tuberculosis.
Lange C, Aarnoutse R, Chesov D, van Crevel R, Gillespie SH, Grobbel HP, Kalsdorf B, Kontsevaya I, van Laarhoven A, Nishiguchi T, Mandalakas A, Merker M, Niemann S, Köhler N, Heyckendorf J, Reimann M, Ruhwald M, Sanchez-Carballo P, Schwudke D, Waldow F, DiNardo AR. Lange C, et al. Among authors: gillespie sh. Front Immunol. 2020 Oct 8;11:566608. doi: 10.3389/fimmu.2020.566608. eCollection 2020. Front Immunol. 2020. PMID: 33117351 Free PMC article. Review.
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.
Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, Pappas F, Phillips PP, Nunn AJ; REMoxTB Consortium. Gillespie SH, et al. N Engl J Med. 2014 Oct 23;371(17):1577-87. doi: 10.1056/NEJMoa1407426. Epub 2014 Sep 7. N Engl J Med. 2014. PMID: 25196020 Free PMC article. Clinical Trial.
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Boeree MJ, Heinrich N, Aarnoutse R, Diacon AH, Dawson R, Rehal S, Kibiki GS, Churchyard G, Sanne I, Ntinginya NE, Minja LT, Hunt RD, Charalambous S, Hanekom M, Semvua HH, Mpagama SG, Manyama C, Mtafya B, Reither K, Wallis RS, Venter A, Narunsky K, Mekota A, Henne S, Colbers A, van Balen GP, Gillespie SH, Phillips PPJ, Hoelscher M; PanACEA consortium. Boeree MJ, et al. Among authors: gillespie sh. Lancet Infect Dis. 2017 Jan;17(1):39-49. doi: 10.1016/S1473-3099(16)30274-2. Epub 2016 Oct 26. Lancet Infect Dis. 2017. PMID: 28100438 Free PMC article. Clinical Trial.
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.
Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, Erkens C, Escalante P, Falzon D, Garcia-Prats AJ, Gegia M, Gillespie SH, Glynn JR, Goldberg S, Griffith D, Jacobson KR, Johnston JC, Jones-López EC, Khan A, Koh WJ, Kritski A, Lan ZY, Lee JH, Li PZ, Maciel EL, Galliez RM, Merle CSC, Munang M, Narendran G, Nguyen VN, Nunn A, Ohkado A, Park JS, Phillips PPJ, Ponnuraja C, Reves R, Romanowski K, Seung K, Schaaf HS, Skrahina A, Soolingen DV, Tabarsi P, Trajman A, Trieu L, Banurekha VV, Viiklepp P, Wang JY, Yoshiyama T, Menzies D. Fregonese F, et al. Among authors: gillespie sh. Lancet Respir Med. 2018 Apr;6(4):265-275. doi: 10.1016/S2213-2600(18)30078-X. Lancet Respir Med. 2018. PMID: 29595509 Free article.
A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA).
Sabiiti W, Mtafya B, De Lima DA, Dombay E, Baron VO, Azam K, Oravcova K, Sloan DJ, Gillespie SH. Sabiiti W, et al. Among authors: gillespie sh. J Vis Exp. 2020 Apr 30;(158). doi: 10.3791/60460. J Vis Exp. 2020. PMID: 32420999
Defining dormancy in mycobacterial disease.
Lipworth S, Hammond RJH, Baron VO, Hu Y, Coates A, Gillespie SH. Lipworth S, et al. Among authors: gillespie sh. Tuberculosis (Edinb). 2016 Jul;99:131-142. doi: 10.1016/j.tube.2016.05.006. Epub 2016 May 28. Tuberculosis (Edinb). 2016. PMID: 27450015 Review.
Mycobacterial Load Assay.
Gillespie SH, Sabiiti W, Oravcova K. Gillespie SH, et al. Methods Mol Biol. 2017;1616:89-105. doi: 10.1007/978-1-4939-7037-7_5. Methods Mol Biol. 2017. PMID: 28600763
243 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page